As Head of Market Access Benelux, you are accountable for the strategic direction, coordination and overall performance of Market Access, Pricing and Reimbursement activities across the Benelux region for the full CSL portfolio.

Your primary focus is on leadership, orchestration and capability development, enabling a skilled team of Market Access professionals to independently manage the majority of operational execution. At the same time, you remain selectively operationally involved in high‑impact or complex topics, such as strategic negotiations, critical HTA dossiers, escalations or key stakeholder interactions. You act as a key interface between local execution and global functional priorities, ensuring strong alignment, quality of execution and continuous development of market access capabilities.

Responsibilities:

Strategy & Oversight

• Define and steer the Benelux Market Access and Pricing strategy in alignment with global and European frameworks.

• Ensure timely, sustainable reimbursement and optimal patient access across NL, BE and LU.

• Provide strategic governance and oversight, while engaging operationally where required for complex or business‑critical initiatives.

Pricing, Reimbursement & Stakeholder Engagement

• Provide strategic leadership and guidance on reimbursement pathways with authorities such as ZIN/VWS (NL), RIZIV/FAGG (BE) and CNS (LU).

• Remain operationally involved in selected high‑impact dossiers, key negotiations or critical HTA procedures.

• Maintain senior‑level relationships with payers, policy makers and other key external stakeholders.

• Support the development and shaping of managed entry agreements and innovative access models.

Team Leadership & Development

• Lead and develop the Benelux Market Access team through clear direction, prioritization and coaching, rather than routine hands‑on execution.

• Empower Market Access Managers and specialists to own and execute reimbursement, HTA and pricing activities independently.

• Act as coach and mentor, actively supporting capability building in areas such as HTA excellence, pricing strategy, negotiations and policy engagement.

• Drive performance management, feedback and talent development in close collaboration with global functional leaders and HR.

• Foster a culture of accountability, ownership and continuous learning.

Matrix Coordination

• Orchestrate collaboration across Market Access, Medical Affairs, Commercial, Finance and Global Market Access.

• Balance regional business needs with global priorities within a complex matrix organization.

• Act as escalation point for strategic, organizational or prioritization challenges.

Tasks:

• Define and steer the Market Access, Pricing and Reimbursement strategy across the Benelux region (NL/BE/LU)

• Coordinate and prioritize Market Access activities within the Benelux and the global matrix organization

• Lead, coach and develop the Market Access team, enabling the team to independently execute day‑to‑day activities

• Ensure governance and quality oversight of HTA submissions, pricing decisions and reimbursement processes

• Align closely with global stakeholders on strategy, positioning and decision‑making

• Manage senior internal and external stakeholders, including payers, governmental bodies and leadership teams

• Content involvement in high‑impact or complex dossiers (e.g. key HTAs, major launches, critical reassessments)

• Participation in strategic negotiations and high‑level payer discussions

Quaifications:

• Degree in health sciences, pharmacy, economics, life sciences or a related field.

• 10+ years of experience in Market Access, including several years in a senior or leadership role.

• Strong knowledge of Dutch and Belgian reimbursement systems (Luxembourg is a plus).

• Proven experience leading teams in a matrix environment, with a coaching and empowering leadership style.

• Ability to combine strategic leadership with selective operational involvement when business‑critical.

• Fluent in English and Dutch; French is a strong asset.

About CSL Vifor

CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology. We specialize in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision healthcare, aiming to help patients around the world lead better, healthier lives. Headquartered in St. Gallen, Switzerland, CSL Vifor also includes the joint company Vifor Fresenius Medical Care Renal Pharma (with Fresenius Medical Care). The parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

 To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.